USA - NASDAQ:BIMI - US05552Q3011 - Common Stock
The current stock price of BIMI is 0.31 USD. In the past month the price decreased by -77.04%. In the past year, price decreased by -85.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.67 | 106.79B | ||
| COR | CENCORA INC | 23.26 | 69.84B | ||
| CAH | CARDINAL HEALTH INC | 22.22 | 47.04B | ||
| HSIC | HENRY SCHEIN INC | 14.54 | 8.50B | ||
| AHCO | ADAPTHEALTH CORP | 25.29 | 1.30B | ||
| AHG | AKSO HEALTH GROUP | N/A | 928.15M | ||
| OMI | OWENS & MINOR INC | 2.42 | 240.99M | ||
| ATPC | AGAPE ATP CORP | N/A | 62.01M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 63.04M | ||
| COSM | COSMOS HEALTH INC | N/A | 20.32M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.17M | ||
| POM | POMDOCTOR LTD - ADR | N/A | 721.30M |
BIMI International Medical, Inc. engages in the provision of healthcare products and services. The company is headquartered in New York City, New York and currently employs 296 full-time employees. The company went IPO on 2010-10-04. The firm offers a range of healthcare products and related services in the United States and Asia. The firm operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.
BIMI INTERNATIONAL MEDICAL I
725 5Th Avenue, 15Th Floor, 15-01
New York City NEW YORK 116000 US
CEO: Tiewei Song
Employees: 296
Phone: 12125420028
BIMI International Medical, Inc. engages in the provision of healthcare products and services. The company is headquartered in New York City, New York and currently employs 296 full-time employees. The company went IPO on 2010-10-04. The firm offers a range of healthcare products and related services in the United States and Asia. The firm operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.
The current stock price of BIMI is 0.31 USD. The price decreased by -35.42% in the last trading session.
BIMI does not pay a dividend.
BIMI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
BIMI stock is listed on the Nasdaq exchange.
BIMI INTERNATIONAL MEDICAL I (BIMI) currently has 296 employees.
The outstanding short interest for BIMI INTERNATIONAL MEDICAL I (BIMI) is 4.63% of its float.
ChartMill assigns a fundamental rating of 1 / 10 to BIMI. BIMI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months BIMI reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS increased by 96.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.51% | ||
| ROE | -122.77% | ||
| Debt/Equity | 0.13 |